Adrenal Insufficiency in Children with Eosinophilic Esophagitis Treated with Topical Corticosteroids.
Identify practices of gastroenterologists screening for adrenal insufficiency (AI) and report prevalence of AI in children with eosinophilic esophagitis (EoE) treated with topical corticosteroids (TCS); compare serum dehydroepiandrosterone sulfate (DHEA-S) levels to morning serum cortisol (MSC) levels as screening tool for AI. A multi-part study was conducted. In Part 1, a survey about screening practices for AI in children with EoE on TCS was sent to gastroenterologists belonging to a PedsGI listserv and to EoE consortia. In Part 2, children with EoE on TCS for ≥ 6 months were prospectively screened for AI with MSC levels. For subjects with a MSC level of < 10 mcg/dL, a repeat MSC level and/or confirmatory ACTH stimulation testing was offered. AI was defined by peak serum cortisol level < 18 mcg/dL. In Part 3, DHEA-S levels were drawn with MSC levels. 7% (16/238) of gastroenterologists screen for AI. Providers in EoE consortia group were more likely to screen than non-consortia providers [9/21(43%) vs 7/217(3%); p = 0.0001]. 37 children were prospectively screened for AI, and 51% (19/37) had a low MSC level. 10 patients had LDST after one or more low MSC levels. 5% (2/37) of patients were diagnosed with AI. DHEA-S and MSC levels had a moderate correlation (rs = 0.44, p = 0.03). Gastroenterologists belonging to EoE consortia were more likely to screen for AI. Prevalence of AI in our prospective cohort was 5%. DHEA-S has a moderate correlation with MSC levels, but more data is required to assess utility as a screening tool for AI.